hotspot -WSS

hotspot

author：leisure time 2025-09-27 23:32:41 - browse：621

A pharmacy technician prepares prescriptions for packaging and shipping after being filled. health policy coverage from STAT — George Frey/Getty Images

WASHINGTON — Republicans and Democrats alike want to stop drug shortages from happening. The vexing question is how.

The White House and a whole host of government agencies oversee programs aimed at mitigating drug shortages, including the Food and Drug Administration, the Administration for Strategic Preparedness and Response, the White House Office of Science and Technology Policy, the Department of Defense, and the Department of Commerce.

The White House also has a new task force that is supposed to put together recommendations for fighting drug shortages, one it formed early this year in response to news of the worsening drug shortage crisis as the country began running out of an increasing number of chemotherapies. It has met with representatives from hospitals, drugmakers, pharmacies, and others in the drug supply chain to brainstorm solutions, but it’s not clear what it has in mind or when it will make those recommendations.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections
Next article： Resistance to opioid

WSS

NEJM study measures Covid brain fog, impact on IQ

There should be a 'Moonshot' or 'Warp Speed' for rare diseases

Cholera vaccine supplies dangerously low, outbreaks surging

Change Healthcare cyberattack shows risk of industry consolidation

Sick patients collapsed waiting for care at Massachusetts hospital with known safety violations

Doctor of U.S. President Joe Biden says he is fit for duty

knowledge

hotspot

explore

As demand for Covid shots wanes, Moderna seeks its next success

Congress considering partial increase for doctor pay in Medicare

Apple is now the first public company to be valued at $3 trillion

Amylyx and the next ALS drug test, plus a chat with CRISPR's CEO

Wildfire smoke exposes gaps in outdoor worker protections

Pfizer is about to make a big push in cancer. Will investors listen?

Medical records are filled with copy

ACIP vaccine advisory panel sees its vacancies filled

Medicare details structure of new drug price negotiation program

Mifepristone protocols being wielded by pill's opponents in Supreme Court case

knowledge

Congress considering partial increase for doctor pay in Medicare

Readout Newsletter: Replicate, Biogen's Leqembi, and Humira

Juul documents reveal insider tactics on political lobbying

Bernie Sanders gets little from pharma CEOs on drug prices

Readout Newsletter: Replicate, Biogen's Leqembi, and Humira

CDC advisory group OKs chikungunya vaccine

explore

hotspot

focus

entertainment